Mark Watt

Mark Watt currently serves as Senior Director of Business Development for Strategic Partners and CRO Partnerships at Signant Health since April 2024. Prior experience includes Associate Director of Global IRT Client Oversight at PPD, where responsibilities included developing IRT bidding strategies and sales solutioning from December 2022 to April 2024. Prior roles at Clario involved leading client success and managing operational oversight for strategic accounts. Mark was also Client/Business Development Manager at Almac Group, overseeing key accounts and managing the end-to-end sales process. Earlier in the career, roles spanned various positions at Norbrook Laboratories Ltd, focusing on pharmaceutical research and development, as well as a clinical conduct role at MDS Pharma Services. Mark holds a BSc Hons in Biology/Biological Sciences from Queen's University Belfast.